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Abstract
In vivo analysis of Drosophila melanogaster has enhanced our understanding of many biological processes, notably the
mechanisms of heredity and development. While in vivo analysis of mutants has been a strength of the field, analyzing fly
cells in culture is valuable for cell biological, biochemical and whole genome approaches in which large numbers of
homogeneous cells are required. An efficient genetic method to derive Drosophila cell lines using expression of an
oncogenic form of Ras (Ras
V12) has been developed. Mutations in tumor suppressors, which are known to cause cell
hyperproliferation in vivo, could provide another method for generating Drosophila cell lines. Here we screened Drosophila
tumor suppressor mutations to test if they promoted cell proliferation in vitro. We generated primary cultures and
determined when patches of proliferating cells first emerged. These cells emerged on average at 37 days in wild-type
cultures. Using this assay we found that a Pten mutation had a strong effect. Patches of proliferating cells appeared on
average at 11 days and the cultures became confluent in about 3 weeks, which is similar to the timeframe for cultures
expressing Ras
V12. Three Pten mutant cell lines were generated and these have now been cultured for between 250 and 630
cell doublings suggesting the life of the mutant cells is likely to be indefinite. We conclude that the use of Pten mutants is a
powerful means to derive new Drosophila cell lines.
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Introduction
The establishment of cell lines from human tissues involves
genetic manipulation of telomerase, tumor suppressors and
oncogenes. Telomerase is required to circumvent the finite
number of divisions most somatic cells experience due to telomere
shortening [1]. In human cells, telomerase expression together
with mutations in tumor suppressors leads to immortality [2].
Rodent cells, in contrast to human cells become immortal
spontaneously at high frequency [3]. Expression of oncogenes
such as Ras allows cells to be independent of growth factors [2].
Expression of oncogenic Ras in human primary cells that lack
telomerase activity causes senescence, but we discovered express-
ing a Ras oncogene (Ras
V12)i nDrosophila primary embryonic cells
promotes cell proliferation to rapidly give rise to immortal cell
lines [4,5,6]. This different response may be because Drosophila
maintains telomere length without telomerase [7]. Expression of
Ras
V12 has proved to be a useful genetic tool to create Drosophila
mutant cell lines [4,8,9]. By analogy with mammalian cells,
inactivation of tumor suppressors could provide another genetic
means to immortalize Drosophila cells. To test this idea we surveyed
a collection of Drosophila tumor suppressor mutants for their ability
to promote proliferation of cells in culture.
Homologs of many mammalian tumor suppressor genes are
conserved in Drosophila and new tumor suppressors have been
discovered in genetic screens using flies. These include both whole
organism screens for larval-pupal lethals with overgrowth
phenotypes in the imaginal discs and screens for tumors that
develop as clonal patches in adults (reviewed in [10]). Analysis of
these genes in Drosophila has made important contributions to
understanding the biology of tumor suppressors and in a number
of cases has supported the involvement of these genes in human
cancers (reviewed in [10]).
Drosophila tumor suppressors are broadly divided into two
classes; neoplastic and hyperplastic that distinguish their different
overgrowth phenotypes [10,11]. The first Drosophila neoplastic
tumor suppressor isolated, lethal (2) giant larvae (lgl) [12,13], was
later found to be part of complex called the Scribble complex
(Scib/Dlg/Lgl), which is required for the establishment and
maintenance of cell polarity in epithelia (reviewed in [11,14,15]).
Loss of function mutations in these and other neoplastic tumor
suppressor genes leads to an increase in cell number, and a failure
to terminally differentiate. The second class, hyperplastic tumor
suppressors, determine proper tissue size by regulating the number
of cells in an organ or tissue (reviewed in [11]). Pten and some
members of the Hippo pathway are well-characterized examples
of hyperplastic tumor suppressors [11,16,17]. Loss of function
mutations in hyperplastic tumor suppressors cause an increase in
cell number, although the ability of the cells to differentiate is not
compromised.
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genes for their ability to promote proliferation of Drosophila cells in
vitro. We found that a Pten mutation had a dramatic effect on
primary cultures. The cultures rapidly became confluent and gave
rise to continuous lines. This identifies Pten mutation as a second
genetic approach for generating cell lines in Drosophila.
Results and Discussion
Primary-culture assay to determine when proliferating
cells appear in tumor-suppressor mutant cultures relative
to wild type and Ras
V12-expressing cultures
Wild-type embryonic primary cultures follow a pattern of
development that initially involves the appearance of morpholog-
ically distinct types of terminally differentiated cell types such as
muscle, nerve and fat body (reviewed in [18]). Patches of
proliferating spindle-shaped, and more rarely epithelial-like, cells
emerge much later than these differentiated cells types and are
likely to be a major cell type that gives rise to continuous lines [18].
These proliferating cell patches appear in wild type cultures after a
delay of several weeks, are often transient, and typically occur in
waves over many months with only the later ones giving rise to
persistent populations [18].
In this study, wild-type cultures followed the expected pattern
with patches of proliferating cells emerging on average at day 37
with a range spanning a few days in individual cultures (Figure 1B
and 1C). These serve as a control to identify genotypes in which
these cells appear earlier, such as cultures expressing oncogenic
Ras
V12 (Act5C-Gal4; UAS- Ras
V12). In Ras
V12 cultures, patches of
proliferating cells appeared on average at about day 8 (Figure 1B).
Changes in the timing of appearance and persistence of
proliferating cells can be an indicator of genotypes that will
readily give rise to continuous cell lines as we discovered for
primary cultures expressing Ras
V12 that readily progressed to
continuous cell lines [4]. Thus, cultures expressing transgenic
Ras
V12 served as a positive control in these assays.
We used the time of appearance of proliferating cell patches, in
comparison with wild-type and Ras
V12-expressing cultures, as an
assay for the effects of tumor suppressor mutations to discover
which, if any, had positive effects and could provide a means for
deriving cell lines. Cultures were established from the progeny of
flies heterozygous for loss-of-function tumor suppressor mutations
(Table 1; Figure 1A). The cultures were, therefore, derived from
embryos of four genotypes but the homozygous mutant cells could
be distinguished in the cultures, as all other genotypes expressed
the marker gene Green Fluorescent Protein (GFP) under the control of
the ubiquitous promoters Actin5C or Ubiquitin (Figure 1A). Several
primary cultures were established for each genotype and examined
every few days over a period of about 8 weeks. The range of days
on which patches of proliferating cells appeared in a given culture
was determined and the GFP marker allowed us to infer the
genotype of the cells. The results are shown in Figure 1B and
discussed below.
Neoplastic tumor suppressor mutants have in vitro
growth characteristics that are similar to wild type
We tested four tumor suppressor mutants, from the neoplastic
class (Table 1). scribble (scrib), discs large 1 (dlg), and lgl, which are
part of the Scribble complex, and brain tumor (brat). The mutants
have overgrowth phenotypes in imaginal discs and neural tissues
and can form tumors when implanted into host flies [10,14,19].
For each mutant strain, multiple primary cultures were established
and the time at which patches of proliferating cells emerged was
determined (Figure 1B). Cultures of each genotype developed
patches of spindle-shaped cells on average between 29 and 37 days
(scrib, 33; dlg, 37; lgl, 31; brat, 29; Figure 1B–D). The range of days
over which these cells appeared overlapped that of wild-type
cultures (Figure 1B). In the long term, the cultures grew slowly
taking on average between 11 and 13 weeks to reach confluence.
In contrast, Ras
V12-expressing cultures, and as we show below Pten
mutant cultures, reach confluence in about three weeks [4]. We
conclude use of the neoplastic mutants, which we tested, is not a
practical approach for the development of cell lines.
Some hyperplastic tumor-suppressor mutants promote
cell proliferation in vitro—Pten is the most potent
We tested 5 hyperplastic tumor suppressor mutants including
the hyperplastic discs (hyd) mutant [20] and 4 genes from two major
signaling pathways; the Hippo pathway (crumbs (crb), hippo (hpo)
and warts (wts)) (reviewed in [17]) and the insulin pathway (Pten)
[16,21,22].
hyd. hyd mutants show a variable disc overgrowth phenotype
as homozygous mutants, which led to classification of the gene as a
tumor suppressor [20]. In the in vitro assay, proliferating patches
appeared on average at 35 days in hyd mutant cultures, which is
similar to the time frame for wild type (Figure 1B). In keeping with
the idea that hyd mutant cells do not have increased ability to
proliferate, clonal mutant patches are small and out competed by
surrounding wild-type cells and some discs in homozygous
mutants are small [20] [23]. The gene has also been found to be
overexpressed, rather than lost, in some human tumors [24].
Hippo pathway. crb mutants represent the group of
hyperplastic tumor suppressors that function upstream in the
Hippo pathway (crb, expanded, merlin and fat) [17,25,26,27,28].
Cultures derived from crb mutants develop proliferating patches on
average at 30 days (Figure 1B). Primary cultures from core
members of the Hippo pathways (hpo and wts) developed patches
of proliferating cells earlier on average at 22 or 21 days,
respectively (Figure 1B and 1E). This was significantly shorter
than the time of appearance of these cells in wild-type cultures
(P,0.005) (Figure 1B; Figure S1). The longer time for the
appearance of proliferating patches in crb mutant cultures is in
keeping with the evidence that genes acting upstream of the core
Hippo pathway appear to play modulating roles which may be
small and additive [17]. Finding that wts mutants lead to the
earlier appearance of proliferating cells is in keeping with our
finding that reducing wts function with RNAi also promoted the
development of proliferating cell patches when compared to
controls [4]. Thus mutants of core tumor suppressor genes in the
Hippo pathway can be used to accelerate the derivation of new cell
lines and indeed we have generated cell lines by expressing wts
RNAi
[4].
Insulin pathway. The occurrence of proliferating cell
patches was earliest and most pronounced in cultures derived
from mutants of the insulin pathway gene Pten, where they
appeared in large numbers on average by 11 days (Figure 1B and
1F). This was significantly shorter than the time of appearance of
these cells in wild-type cultures (P,0.001) (Figure 1B; Figure S1).
We tracked the development of Pten mutant primary cultures over
longer periods and found they mirrored the development of
cultures expressing Ras
V12: they reached confluence at about 3
weeks and the 10
th passage by 5 months (Table 2; [4]). The time of
the appearance of proliferating cells in Pten cultures compared with
Ras
V12 cultures was not significantly different (Figure S1). Three
cell lines were generated (Pten-1, -1A and -X; Table 2). These lines
have been passaged multiple times representing between 250 and
630 cell doublings and thus can be considered immortal. The lines
were established from the null allele, Pten
117, which has a deletion
Continuous Drosophila Cell Lines from Pten Mutants
PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e31417Figure 1. Time of appearance of proliferating cell patches in wild-type and tumor-suppressor mutant primary cultures. (A) Cross to
generate embryos for tumor suppressor primary cultures. Tumor suppressor (ts) mutants were maintained in stocks with a marked balancer
chromosome that expresses a GFP transgene (Bal, GFP). One quarter of the progeny embryos are the desired class (boxed genotype). Primary cultures
were established from mixed embryos and cells homozygous for the ts allele could be recognized because they are GFP negative. (B) The average
day, and the range of days at which proliferating cells appear is shown. The number of cultures for each genotype is given (n). Wild-type control and
Act-Gal4; UAS-Ras
V12 positive control (blue); neoplastic mutants (red); hyperplastic mutants (green). The appearance of proliferating cells in Pten and
Ras
V12 cultures was significantly earlier than in wild-type control cultures (P,0.001). The appearance of proliferating cells in wts and hippo cultures
was also significantly earlier than in wild-type control cultures (P,0.05). There were no significant differences between wild-type control cultures and
any of the neoplastic mutants. See also Figure S1. (C–F) Examples of cultures showing proliferating patches that first appeared on average at about
33–37 days in wild type (C) and scribble (D), 21 days in hippo (E) and 11 days in Pten (F). Differentiated cell types such as muscle (arrowhead) and fat
(open arrowhead) are present in all genotypes. Insets in D–F show a GFP image demonstrating that the indicated patches of proliferating cells
(arrows) were negative for GFP and therefore of the mutant genotype.
doi:10.1371/journal.pone.0031417.g001
Table 1. Tumor suppressors tested in in vitro assays.
Gene (allele used*) Mammalian homolog
Tumor suppressor class and
Complex or Pathway GO classification**
Molecular function Biological Process
scribble (scrib
1) Scrib neoplastic Scrib/Dlg/Lgl kinase regulator signal transduction cell
adhesion
discs large 1 (dlg
XI-2) Dlg1 neoplastic Scrib/Dlg/Lgl unknown-protein interaction
domains
signal transduction cell
adhesion
lethal (2) giant larvae (lgl
4) Llgl1 neoplastic Scrib/Dlg/Lgl signal transduction cell
adhesion
brain tumor (brat
11) TRIM neoplastic Myc regulation E3 ubiquitin-protein ligase cell cycle nervous system
hyperplastic discs (hyd
35)E D D hyperplastic ubiquitin-protein ligase activity protein metabolic process
crumbs (crb
2) Crb1 hyperplastic wts/hpo pathway transmembrane EGF apical/basal polarity
hippo (hpo
BF33) MST1/2 hyperplastic wts/hpo pathway kinase signal transduction apoptosis
cell cycle
warts (wts
MGH1) LATS1/2 hyperplastic wts/hpo pathway kinase signal transduction apoptosis
cell cycle
Pten (Pten
117) Pten hyperplastic insulin pathway phosphatase cell cycle, signal transduction
*The allele used in this study is indicated. All alleles used were loss-of-function and when possible null alleles. The alleles and their sources are described in the methods
section.
**GO classification adapted from Panther (http://www.pantherdb.org/).
doi:10.1371/journal.pone.0031417.t001
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line genotype was confirmed using PCR (see methods). Together
these results support the use of a loss-of-function Pten mutation as a
practical strategy for deriving new Drosophila cell lines.
Pten
117 mutant and Ras
V12-expressing primary cells show
comparable accelerated growth in culture, but the
combination has no added effect
As loss of Pten accelerated the appearance of proliferating cells,
when compared to wild type and all other tumor suppressor
mutants tested (Figure 1B), the mutant primary cultures were
examined more closely and compared with the development of
Ras
V12 expressing cultures. We also tested whether simultaneous
loss of Pten and expression of Ras
V12 had an additive effect.
Cultures were established from controls, and stocks that gave rise
to Pten mutant embryos, embryos expressing transgenic Ras
V12,
and Pten mutant embryos expressing transgenic Ras
V12.
Initially, the cell types and their morphologies were very similar
in all cultures (Figure 2A, 2D, 2G, 2J), however, after 10 days,
there were marked differences between the mutant and control
genotypes. Pten, Ras
V12, and Pten; Ras
V12 cultures had numerous
small patches of spindle-shaped cells and more rarely patches of
epithelial-like cells (Figure 2E, 2H, 2K), whereas control cultures
had only differentiated cell types (Figure 2B). By 20 days these
differences were more pronounced and the mutant cultures were
densely populated with proliferating cells (Figure 2F, 2I, 2L). At
this stage control cultures still remained sparse and comprised of
differentiated cell types (Figure 2C). The Pten mutant cultures also
expressing Ras
V12 developed in a similar fashion to those mutant
for Pten alone or those just expressing Ras
V12. We generated two
cell lines from Pten; Ras
V12 cultures and these also developed in a
similar fashion to those derived from cells with the single genetic
changes (Table 2).
We examined pathway activation in the primary cultures and
found as expected that Akt signaling was activated in Pten mutant
cultures (Figure 2M). Pten is a key negative regulator of Akt
signaling. We also examined MAPK/Erk signaling as determined
by phosphorylation of Drosophila Erk a downstream effector of Ras
signaling. Pten cultures showed wild-type levels of Erk activation
(Figure 2N). As expected, primary cultures expressing Ras
V12 had
high levels of Erk activation (Figure 2N). It is known that Drosophila
Ras
V12, but probably not endogenous Ras, can also signal through
the Akt pathway [4,30,31]. In keeping with our previous findings
for Ras
V12 expression in vitro, we also observed enhanced Akt
activation in Ras
V12-expressing primary cultures ([4]; Figure 3M).
The Pten; Ras
V12 cultures showed strong activation of both
pathways (Figure 2M, 2N). We conclude that the combination
of molecular changes resulting from the different genetic
backgrounds does not result in additive effects at the cellular level
that can further enhance cell proliferation.
Characteristics of Pten, Ras
V12, and Pten; Ras
V12 cell lines
We compared characteristics of Pten
117 and Pten
117; Ras
V12 cell
lines with Ras
V12 lines and cells of the commonly used Drosophila S2
line [32]. The cells have different morphologies likely reflecting
different cell types (Figure 3A–H). All lines, including S2, were
generated from whole embryos and, therefore, the cell type is not
known a priori, although subsequent analysis of S2 cells suggest
they are of macrophage origin [33]. All lines showed doubling
times between 31 h and 43 h at 22uC during the steepest part of
the growth curve and achieved a broad range of confluent
densities (Table 2). Differences in doubling times and confluent
densities could reflect in part the different cell types present in the
lines, but it is also likely that there is a genetic component
conferred by the Pten mutation. The Pten
117 mutant lines had the
longest doubling times (Table 2). The Pten
117 and the Pten
117;
Ras
V12 expressing lines mutant lines also had significantly lower
confluent densities than the Ras
V12 expressing lines (Table 2). Thus
cells with a mutation in Pten fail to reach high confluent densities
even in the presence of Ras
V12. Further analysis will be required to
determine the molecular basis for the effect. By the measures of
doubling time and confluent density alone, the Pten
117 lines have
less practical use because growing the cells takes longer and not as
many cells can be generated in a culture vessel. However, as
discussed below there are likely to be cases in which having an
additional genetic method to generate cell lines will be critical.
Pten
117 mutant cell cultures will also be key reagents for studying
the immortalization process itself.
Western analysis of the lines showed the expected pathways
were strongly activated; Akt in Pten
117 mutant lines, Erk in the
Ras
V12 expressing lines and both in the Pten
117; Ras
V12 lines
(Figure 3I). S2 cells showed only basal activation of Erk (Figure 3I).
The Ras 7 line showed activation of PI3K (Figure 3I), as has been
noted for cells expressing the Ras
V12 allele in vivo [30,31] and in vitro
[4]. Cells of the line Pten X, showed higher levels of Erk activation
than the other two Pten lines demonstrating that individual lines
can differ presumably either due to the specific cell type present in
the line or through additional genetic changes that occur during
prolonged culture (Figure 3I). In S2 cells there was no activation of
Akt, which is a target of insulin signaling, and only weak activity of
Erk signaling (Figure 3I). Analysis of S2 cells has shown that the
insulin receptor is expressed, but the pathway is unlikely to be
active because the ligands are not expressed [34]. The PVR
pathway is thought to be active and could be contributing to the
activation of Erk we observed [34].
Concluding remarks
Our major finding is that Pten loss promotes cell proliferation in
vitro and allows the rapid derivation of cell lines, providing another
genetic method to generate cell lines in Drosophila in addition to the
use of oncogenic Ras
V12 [4]. We have successfully used expression
of transgenic Ras
V12 to derive cell lines from the rumi mutant [8].
The cells, which are null for rumi have been used to study Notch
signaling in vitro [9]. In a similar fashion Pten mutations could be
used to establish cell lines corresponding to mutants. This is
Table 2. Generation and characteristics of Pten cell lines in
reference to other cell lines.
Cell line
Weeks to
confluence
Months to
passage 10
Doubling
time (h)
(226C)
Confluent
density
(610
6)*
Pten 1 3 5 43 2.3
Pten 1A 3 5 40 3.2
Pten X N/D N/D 42 2.3
Ras 3 3 4 31 7.0
Ras 7 3 4 32 8.9
Pten Ras 8 5 4 36 3.5
Pten Ras 9 5 4 36 3.2
S2 N/A N/A 33 6.5
*surface area=3.8 cm
2.
ANOVA and a Tukey-Kramer multiple comparison test showed that Pten and
Pten; Ras lines had a significantly lower confluent density than Ras lines
(P,0.01) (F value=31.052=MStreatment/MSresidual).
doi:10.1371/journal.pone.0031417.t002
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which to study a mutant where having the Ras pathway active
would interfere with the analysis.
Materials and Methods
Fly stocks
CyO, Act5C-GFP; TM6B, Ubi-GFP; FM7i, Act-GFP, crb
2 and
l(2)gl
4 flies were obtained from the Bloomington Drosophila
Stock Center. The GFP-marked balancer chromosomes were
used to generate stocks of the tumor suppressor mutations.
The following alleles were obtained from colleagues: hpo
BF33,J .
Jiang [35]; wts
MGH1, D.J. Pan [36]; brat
11, D. Frank [37]; Pten
117,
H. Stocker [29]; hyd
35, J. Treisman [20]; scrib
1, D. Bilder [38];
dlg
XI-2, V. Budnik [39]. Pten
117, UAS-RAS
V12 and Pten
117, Act5C-
Gal4 recombinant chromosomes were generated using standard
crosses.
Cell culture
Primary cultures were established using a standard method [4].
Schneider’s medium with 10% heat inactivated Fetal Bovine
serum was used for all cell culture work. Multiple primary cultures
were generated for each genotype and examined to document the
development of various cells types. The time at which patches of
dividing cells emerged was determined. Cultures of Pten
117 and
Pten
117; Ras
V12 cells were maintained until they reached confluence
and were sub-cultured to generate cell lines using standard
methods [4].
Cell line characterization
For growth curves, cells were plated at 2.5610
5 cells/well in a
12-well plate with 1 ml of medium. Duplicate cell counts were
made over 7 days. Doubling time was determined during the
period when cells numbers increased most steeply in a given line
Figure 2. Pten mutant primary cultures mirror the development of primary cultures expressing oncogenic Ras
V12. (A–C) Wild type. (D–
F) Ras
V12 (Act5C-Gal4; UAS-Ras
V12). (G–I) Pten
117. (J–L) Pten
117; Ras
V12 (Pten
117; Act5C-Gal4/Pten
117; UAS-Ras
V12). After five days, primary cultures of all
genotypes (A, D, G, J) had differentiated cell types including fat body (open arrowheads) and muscle (arrowheads). After ten days, wild-type cultures
(B) had only the same differentiated cell types, whereas, cultures of the other genotypes (E, H, K) had patches of spindle-shaped cells. After 20 days,
wild-type cultures (C) had only the same differentiated cell types, whereas, cultures of the other genotypes (F, I, L) were densely populated with
spindle-shaped cells. (M and N) Western-blot analysis of primary culture extracts with cells of the indicated genotypes. (M) The Akt pathway is
activated (pAkt) above control (wild type) levels in cultures with Ras
V12 expressing cells (Ras
V12), Pten mutant cells (Pten
117) and Pten mutant cells
expressing Ras
V12 (Pten
117; Ras
V12). The Erk pathway is activated (dpErk) above control (wild type) levels in cultures with Ras
V12 expressing cells (Ras
V12)
and Pten mutant cells expressing Ras
V12 (Pten
117; Ras
V12). Total Akt and Erk, as detected by a-Akt and a-Erk were used as loading controls [40,41]. Akt
is detected as two bands (Cell Signaling Technology) [31]. For unknown reasons the lower band is more prominent in the Pten mutant cultures.
doi:10.1371/journal.pone.0031417.g002
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point when there was no further increase in cell number.
Genotyping of Pten mutant cell lines
The Pten
117 allele has a deletion of 5 base pairs in the coding
region of the gene that results in a frame-shift and insertion of a
premature stop codon. DNA from Pten cultures was amplified
using the primers shown below. The amplified DNA was purified
and sequenced to confirm presence of the mutation.
59-GCGAAAGTTCATAAATATCATGGC, 39-CGGCGCT
GAATGTGGCGC.
Western Analysis
Cells were lysed in TN1 buffer containing 125 mM NaCl,
50 mM Tris (pH=8.0), 10 mM EDTA (pH=8.0), 10 mM
Na4P2O7 ?10H2O, 10 mM NaF, 1% Triton X-100, 3 mM
Na3VO4 supplemented with protease inhibitor cocktail (Roche
Diagnostics Corp. Indianapolis, IN), centrifuged, and supernatants
were used for analysis. Total protein (10 mg) was separated on
polyacrylamide gels and immunoblots were incubated with
antibodies directed against Drosophila-specific Akt and pAkt (Ser
505) (Cell Signaling Technology; Danvers, MA), pan-Erk, (Santa
Cruz Biotechnology; Santa Cruz, CA) and dpErk1/2 (E10) (Cell
Signaling Technology; Danvers, MA).
Supporting Information
Figure S1 Statistical analysis of cell proliferation data.
Box and whisker plot of the data from Figure 1B in the main text
showingthe time for proliferatingcells to appear inprimarycultures
of different genotypes. Boxes are drawn between the mean and the
median. The whiskers end at the maximum and minimum values in
the sample population. Samples were analyzed using Dunn’s
multiple comparison test post the Kruskal-Wallis test. Pairs that
were identified as significantly different are connected by solid lines.
Both Pten mutant and Ras
V12 expressing cultures are significantly
different than wild-type cultures (P,0.001). Both hpo and wts
cultures are significantly different than wild-type cultures (P,0.05).
(PDF)
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Figure 3. Morphological and molecular comparison of Pten
117 cell lines with S2, Ras
V12 and Pten
117; Ras
V12 cell lines. (A–H) Cells are
shown after 6 days of growth from the same starting cell number. (A) S2. Cells show the typical round morphology and are loosely attached to the
surface. (B–D) Pten
117. Pten 1 and 1A have round and spindle-shaped cells. Cells in the Pten 1 line are more loosely attached. Cells in line Pten X are
primarily spindle shaped. (E–F) Ras
V12. Ras 7 and 3 have spindle shaped cells that form dense attached clusters. (G–H) Pten
117; Ras
V12. Pten; Ras 8 and 9
have spindle shaped cells that form small clusters. (I) Western-blot analysis of cell extracts from the indicated lines. The Akt pathway is activated
(pAkt) above control levels in all lines with Pten mutations. The Ras 7 line also shows elevated activation. The Erk pathway is activated (dpErk) in most
lines with very low levels in S2 cells and undetectable levels in line Pten 1. Total Akt and Erk, as detected by a-Akt and a-Erk were used as loading
controls [40,41]. Akt is detected as two bands (Cell Signaling Technology) [31].
doi:10.1371/journal.pone.0031417.g003
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